Connors Investor Services Inc Elanco Animal Health Inc Transaction History

Connors Investor Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$28.76 - $35.98 $451,244 - $564,526	-15,690 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$27.53 - $33.79 $580,883 - $712,969	-21,100 Reduced 57.35%	15,690 $481,000
Q3 2020 Nov 16, 2020	SELL	$21.1 - $29.13 $11,394 - $15,730	-540 Reduced 1.45%	36,790 $1.03 Million
Q2 2020 Aug 14, 2020	SELL	$18.94 - $24.93 $13,258 - $17,451	-700 Reduced 1.84%	37,330 $801,000
Q1 2020 May 14, 2020	SELL	$16.68 - $32.25 $5.25 Million - $10.1 Million	-314,625 Reduced 89.22%	38,030 $851,000
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $8.92 Million - $10.4 Million	352,655 New	352,655 $10.4 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

Stay updated on Connors Investor Services Inc with notifications on news.